We are live on ! Find out more
BDF

Balasa Dinverno & Foltz Portfolio holdings

AUM $1.58B
1-Year Est. Return 17.55%
This Fund
S&P 500
This Quarter Est. Return
-14.12%
1 Year Est. Return
-17.55%
3 Year Est. Return
+23.2%
5 Year Est. Return
+47.16%
10 Year Est. Return
AUM
$1.59B
AUM Growth
+$108M
Cap. Flow
+$377M
Cap. Flow %
23.68%
Top 10 Hldgs %
57.04%
Holding
374
New
30
Increased
160
Reduced
124
Closed
41

Sector Composition

Rank Sector Weight
1 Technology 5.4%
2 Healthcare 3.75%
3 Financials 2.84%
4 Consumer Staples 1.85%
5 Consumer Discretionary 1.62%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
JNJ icon
26
Johnson & Johnson
JNJ
$631B
$7.29M 0.46%
41,079
+1,086
+3% +$193K
DFAX icon
27
Dimensional World ex US Core Equity 2 ETF
DFAX
$12.4B
$6.49M 0.41%
302,897
-227
-0.1% -$5.28K
SPYV icon
28
State Street SPDR Portfolio S&P 500 Value ETF
SPYV
$36.6B
$6.2M 0.39%
+168,420
New +$6.67M
LRGF icon
29
iShares US Equity Factor ETF
LRGF
$3.71B
$5.83M 0.37%
153,709
-3,653
-2% -$150K
AMZN icon
30
Amazon
AMZN
$3T
$5.34M 0.34%
50,271
-2,249
-4% -$281K
LLY icon
31
Eli Lilly
LLY
$1.1T
$5.15M 0.32%
15,877
+2,298
+17% +$690K
MET icon
32
MetLife
MET
$61.7B
$5.1M 0.32%
81,163
-7,260
-8% -$481K
SUB icon
33
iShares Short-Term National Muni Bond ETF
SUB
$11.4B
$4.99M 0.31%
+47,659
New +$4.96M
ABBV icon
34
AbbVie
ABBV
$438B
$4.89M 0.31%
31,946
+1,445
+5% +$221K
SPY icon
35
State Street SPDR S&P 500 ETF Trust
SPY
$810B
$4.81M 0.3%
12,744
+27
+0.2% +$11.1K
CVS icon
36
CVS Health
CVS
$122B
$4.8M 0.3%
51,767
-5,372
-9% -$524K
PFE icon
37
Pfizer
PFE
$154B
$4.45M 0.28%
84,781
-4,885
-5% -$249K
NVDA icon
38
NVIDIA
NVDA
$5.27T
$4.43M 0.28%
292,050
-21,540
-7% -$407K
HD icon
39
Home Depot
HD
$350B
$4.09M 0.26%
14,901
+864
+6% +$255K
PG icon
40
Procter & Gamble
PG
$340B
$4.05M 0.25%
28,180
+103
+0.4% +$15.5K
WMT icon
41
Walmart Inc
WMT
$897B
$3.94M 0.25%
97,335
-15,810
-14% -$729K
ACN icon
42
Accenture
ACN
$109B
$3.5M 0.22%
12,613
+436
+4% +$131K
UNM icon
43
Unum
UNM
$14.5B
$3.21M 0.2%
94,275
+5,512
+6% +$187K
INTU icon
44
Intuit
INTU
$91.5B
$3.19M 0.2%
8,265
-140
-2% -$58K
PWR icon
45
Quanta Services
PWR
$99.4B
$3.08M 0.19%
24,597
-539
-2% -$66.2K
TGT icon
46
Target
TGT
$69B
$3.08M 0.19%
21,778
-5,101
-19% -$978K
TSLA icon
47
Tesla
TSLA
$1.31T
$3.06M 0.19%
13,635
-1,626
-11% -$444K
IVW icon
48
iShares S&P 500 Growth ETF
IVW
$77.4B
$3.02M 0.19%
50,100
-1,030
-2% -$68.2K
BRK.B icon
49
Berkshire Hathaway Class B
BRK.B
$1.13T
$3.02M 0.19%
11,060
-139
-1% -$43.6K
GOOG icon
50
Alphabet (Google) Class C
GOOG
$4.35T
$2.96M 0.19%
27,040
+2,020
+8% +$239K

Similar funds

Balasa Dinverno & Foltz's Q2 2022 Portfolio in Review

As of Q2 2022, Balasa Dinverno & Foltz held 374 positions worth $1.59B, up 7.3% from $1.48B the previous quarter. Its ten largest holdings account for 57% of the portfolio.

Balasa Dinverno & Foltz deployed $377M of net new capital in Q2 2022, opening 30 new positions and adding to 160 existing holdings. Its largest new stake was Dimensional US Marketwide Value ETF: 7,658,446 shares worth $242M.

By sector, the portfolio is most concentrated in Technology at 5.4% of assets, down from 7.2% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was Dimensional US Targeted Value ETF, an estimated $7.19M trimmed.

  • Balasa Dinverno & Foltz's largest Q2 2022 buy was Dimensional US Marketwide Value ETF: 7,658,446 shares worth $242M.
  • Balasa Dinverno & Foltz added most to Dimensional US Small Cap Value ETF in Q2 2022, an estimated $12.3M increase.
  • Balasa Dinverno & Foltz's biggest Q2 2022 reduction was Dimensional US Targeted Value ETF, cutting an estimated $7.19M.
  • Balasa Dinverno & Foltz fully exited Cerner Corp in Q2 2022, selling an estimated $1.23M.
  • Balasa Dinverno & Foltz's ten largest holdings make up 57% of its $1.59B portfolio in Q2 2022.
  • Balasa Dinverno & Foltz opened 30 new positions and closed 41 in Q2 2022.
  • Balasa Dinverno & Foltz's portfolio value rose 7.3% quarter-over-quarter to $1.59B.

Based on Balasa Dinverno & Foltz's 13F filing for Q2 2022, filed 9 Aug 2022.